Etomidate, a new water-soluble non-barbiturate intravenous induction agent

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Intravenous induction agents are crucial for anesthesia.
• Non-barbiturate agents offer potential safety advantages.

Purpose of the Study:

• To describe the clinical experience with etomidate, a novel water-soluble, non-barbiturate induction agent.
• To evaluate the efficacy and safety profile of etomidate in patients undergoing anesthesia.

Main Methods:

• Clinical experience documented in 100 patients.
• Administration of etomidate as an intravenous induction agent.
• Observation of induction time, cardiovascular parameters (pulse rate, blood pressure), respiratory effects (apnea), and adverse events (involuntary movements).

Main Results:

• Etomidate induced sleep within one arm-to-brain circulation time.
• No significant effect on pulse rate was observed.
• A slight decrease in blood pressure and a low frequency of apnea were noted.
• Involuntary movements were observed, ranging from mild to severe in some patients.

Conclusions:

• Etomidate demonstrates rapid onset of action for intravenous anesthesia.
• The drug exhibits a generally favorable cardiovascular and respiratory safety profile.
• The occurrence of involuntary movements necessitates further evaluation before widespread clinical adoption.